第一单位：
Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen 72076, Germany; HepaRegeniX GmbH, Tübingen 72072, Germany.
作者：
Stefan,Zwirner [1]
;
Anan A,Abu Rmilah [2]
;
Sabrina,Klotz [3]
;
Bent,Pfaffenroth [4]
;
Philip,Kloevekorn [4]
;
Athina A,Moschopoulou [3]
;
Svenja,Schuette [3]
;
Mathias,Haag [5]
;
Roland,Selig [6]
;
Kewei,Li [2]
;
Wei,Zhou [2]
;
Erek,Nelson [2]
;
Antti,Poso [7]
;
Harvey,Chen [2]
;
Bruce,Amiot [2]
;
Yao,Jia [2]
;
Anna,Minshew [2]
;
Gregory,Michalak [2]
;
Wei,Cui [3]
;
Elke,Rist [3]
;
Thomas,Longerich [8]
;
Birgit,Jung [9]
;
Philipp,Felgendreff [2]
;
Omelyan,Trompak [3]
;
Prem K,Premsrirut [10]
;
Katharina,Gries [3]
;
Thomas E,Muerdter [5]
;
Georg,Heinkele [5]
;
Torsten,Wuestefeld [11]
;
David,Shapiro [9]
;
Markus,Weissbach [9]
;
Alfred,Koenigsrainer [12]
;
Bence,Sipos [3]
;
Eiso,Ab [13]
;
Magdalena Ortiz,Zacarias [13]
;
Stephan,Theisgen [13]
;
Nicole,Gruenheit [14]
;
Saskia,Biskup [14]
;
Matthias,Schwab [15]
;
Wolfgang,Albrecht [9]
;
Stefan,Laufer [16]
;
Scott,Nyberg [17]
;
Lars,Zender [18]
作者单位：
Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen 72076, Germany; HepaRegeniX GmbH, Tübingen 72072, Germany.
[1]
William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN 55905, USA.
[2]
Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen 72076, Germany.
[3]
Department of Pharmaceutical Chemistry, University of Tübingen, Tübingen 72076, Germany.
[4]
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart 70376, Germany.
[5]
HepaRegeniX GmbH, Tübingen 72072, Germany; Department of Pharmaceutical Chemistry, University of Tübingen, Tübingen 72076, Germany.
[6]
Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen 72076, Germany; School of Pharmacy, University of Eastern Finland, Kuopio 70211, Finland; iFIT Cluster of Excellence (EXC 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen 72076, Germany.
[7]
Institute of Pathology, University Hospital Heidelberg, Heidelberg 69120, Germany.
[8]
HepaRegeniX GmbH, Tübingen 72072, Germany.
[9]
Mirimus Inc, 760 Parkside Ave, Brooklyn, NY 11226, USA.
[10]
Laboratory for In Vivo Genetics & Gene Therapy, Genome Institute of Singapore, Agency for Science, Technology and Research (A(∗)STAR), Singapore 138672, Singapore; School of Biological Sciences, Nanyang Technological University of Singapore, Singapore 637551, Singapore.
[11]
iFIT Cluster of Excellence (EXC 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen 72076, Germany; German Cancer Research Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Department of General-, Visceral, and Transplant Surgery, University Hospital Tübingen, Tübingen 72076, Germany.
[12]
ZoBio B.V., Leiden 2333 CH, the Netherlands.
[13]
CeGaT GmbH, Tübingen 72076, Germany.
[14]
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart 70376, Germany; iFIT Cluster of Excellence (EXC 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen 72076, Germany; Department of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tübingen, Tübingen 72076, Germany.
[15]
Department of Pharmaceutical Chemistry, University of Tübingen, Tübingen 72076, Germany; Tübingen Center for Academic Drug Discovery & Development (TüCAD(2)), Tübingen 72076, Germany. Electronic address: stefan.laufer@uni-tuebingen.de.
[16]
William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: nyberg.scott@mayo.edu.
[17]
Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen 72076, Germany; iFIT Cluster of Excellence (EXC 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen 72076, Germany; German Cancer Research Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Tübingen Center for Academic Drug Discovery & Development (TüCAD(2)), Tübingen 72076, Germany. Electronic address: lars.zender@med.uni-tuebingen.de.
[18]
DOI
10.1016/j.cell.2024.02.023
PMID
38490194
发布时间
2024-07-15
换一批
